Advertisement

Index by Author

July 1994; 43 (7)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Arslanian, S A

    • Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty. Diabetes July 1994 43:908-914; doi:10.2337/diabetes.43.7.908

B

  1. Baird, A

    • Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes July 1994 43:947-953; doi:10.2337/diabetes.43.7.947

  2. Beattie, G M

    • Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes July 1994 43:947-953; doi:10.2337/diabetes.43.7.947

  3. Betterle, C

    • Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies. Diabetes July 1994 43:851-856; doi:10.2337/diabetes.43.7.851

  4. Bhanot, S

    • Bis(maltolato)oxovanadium(IV) attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats. Diabetes July 1994 43:857-861; doi:10.2337/diabetes.43.7.857

  5. Bolli, G B

    • Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes July 1994 43:920-928; doi:10.2337/diabetes.43.7.920

  6. Bonifacio, E

    • Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies. Diabetes July 1994 43:851-856; doi:10.2337/diabetes.43.7.851

  7. Bosi, E

    • Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies. Diabetes July 1994 43:851-856; doi:10.2337/diabetes.43.7.851

  8. Bottazzo, G F

    • Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies. Diabetes July 1994 43:851-856; doi:10.2337/diabetes.43.7.851

  9. Brunetti, P

    • Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes July 1994 43:920-928; doi:10.2337/diabetes.43.7.920

  10. Bryer-Ash, M

    • Bis(maltolato)oxovanadium(IV) attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats. Diabetes July 1994 43:857-861; doi:10.2337/diabetes.43.7.857

C

  1. Carnaghi, L R

    • Time course for effects of hypoglycemia on insulin gene transcription in vivo. Diabetes July 1994 43:929-934; doi:10.2337/diabetes.43.7.929

  2. Chen, H

    • Proximal enhancer of the human insulin receptor gene binds the transcription factor Sp1. Diabetes July 1994 43:884-889; doi:10.2337/diabetes.43.7.884

  3. Chen, S

    • More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling. Diabetes July 1994 43:878-883; doi:10.2337/diabetes.43.7.878

  4. Cheung, A

    • Bis(maltolato)oxovanadium(IV) attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats. Diabetes July 1994 43:857-861; doi:10.2337/diabetes.43.7.857

  5. Christie, M R

    • Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies. Diabetes July 1994 43:851-856; doi:10.2337/diabetes.43.7.851

  6. Cochran, C

    • Non-insulin-mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis. Diabetes July 1994 43:890-896; doi:10.2337/diabetes.43.7.890

  7. Curatola, G

    • Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes July 1994 43:915-919; doi:10.2337/diabetes.43.7.915

D

  1. Dagogo-Jack, S

    • Isolation of the human LIM/homeodomain gene islet-1 and identification of a simple sequence repeat polymorphism [corrected] Diabetes July 1994 43:935-941; doi:10.2337/diabetes.43.7.935

  2. Dela, F

    • Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes July 1994 43:862-865; doi:10.2337/diabetes.43.7.862

  3. Donis-Keller, H

    • Isolation of the human LIM/homeodomain gene islet-1 and identification of a simple sequence repeat polymorphism [corrected] Diabetes July 1994 43:935-941; doi:10.2337/diabetes.43.7.935

  4. Dousset, N

    • Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes July 1994 43:915-919; doi:10.2337/diabetes.43.7.915

E

  1. Eastman, R C

    • Non-insulin-mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis. Diabetes July 1994 43:890-896; doi:10.2337/diabetes.43.7.890

  2. Eklund, L

    • Effects of hyperglycemia on in vivo adipose tissue metabolism studied with microdialysis in IDDM subjects. Diabetes July 1994 43:866-870; doi:10.2337/diabetes.43.7.866

  3. Elliott, R B

    • Early environmental events as a cause of IDDM. Evidence and implications. Diabetes July 1994 43:843-850; doi:10.2337/diabetes.43.7.843

F

  1. Ferrannini, E

    • Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes July 1994 43:920-928; doi:10.2337/diabetes.43.7.920

  2. Ferretti, G

    • Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes July 1994 43:915-919; doi:10.2337/diabetes.43.7.915

  3. Foster, D W

    • More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling. Diabetes July 1994 43:878-883; doi:10.2337/diabetes.43.7.878

  4. Foulis, A

    • Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies. Diabetes July 1994 43:851-856; doi:10.2337/diabetes.43.7.851

  5. Froguel, P

    • Isolation of the human LIM/homeodomain gene islet-1 and identification of a simple sequence repeat polymorphism [corrected] Diabetes July 1994 43:935-941; doi:10.2337/diabetes.43.7.935

  6. Fumelli, P

    • Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes July 1994 43:915-919; doi:10.2337/diabetes.43.7.915

G

  1. Galassi, R

    • Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes July 1994 43:915-919; doi:10.2337/diabetes.43.7.915

  2. Galbo, H

    • Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes July 1994 43:862-865; doi:10.2337/diabetes.43.7.862

  3. Genovese, S

    • Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies. Diabetes July 1994 43:851-856; doi:10.2337/diabetes.43.7.851

  4. Giddings, S J

    • Time course for effects of hypoglycemia on insulin gene transcription in vivo. Diabetes July 1994 43:929-934; doi:10.2337/diabetes.43.7.929

  5. Goff, D C

    • The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes July 1994 43:897-902; doi:10.2337/diabetes.43.7.897

  6. Griver, K

    • Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM. Diabetes July 1994 43:871-877; doi:10.2337/diabetes.43.7.871

  7. Gulve, E A

    • Lithium increases susceptibility of muscle glucose transport to stimulation by various agents. Diabetes July 1994 43:903-907; doi:10.2337/diabetes.43.7.903

  8. Gumbiner, B

    • Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM. Diabetes July 1994 43:871-877; doi:10.2337/diabetes.43.7.871

H

  1. Haffner, S M

    • Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes July 1994 43:942-946; doi:10.2337/diabetes.43.7.942

  2. Handberg, A

    • Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes July 1994 43:862-865; doi:10.2337/diabetes.43.7.862

  3. Hayek, A

    • Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes July 1994 43:947-953; doi:10.2337/diabetes.43.7.947

  4. Henry, R R

    • Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM. Diabetes July 1994 43:871-877; doi:10.2337/diabetes.43.7.871

  5. Herbst, T

    • Time course for effects of hypoglycemia on insulin gene transcription in vivo. Diabetes July 1994 43:929-934; doi:10.2337/diabetes.43.7.929

  6. Holloszy, J O

    • Lithium increases susceptibility of muscle glucose transport to stimulation by various agents. Diabetes July 1994 43:903-907; doi:10.2337/diabetes.43.7.903

J

  1. Jansson, P A

    • Effects of hyperglycemia on in vivo adipose tissue metabolism studied with microdialysis in IDDM subjects. Diabetes July 1994 43:866-870; doi:10.2337/diabetes.43.7.866

K

  1. Kalhan, S C

    • Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty. Diabetes July 1994 43:908-914; doi:10.2337/diabetes.43.7.908

L

  1. Labarthe, D R

    • The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes July 1994 43:897-902; doi:10.2337/diabetes.43.7.897

  2. Larsen, J J

    • Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes July 1994 43:862-865; doi:10.2337/diabetes.43.7.862

  3. Leslie, R D

    • Early environmental events as a cause of IDDM. Evidence and implications. Diabetes July 1994 43:843-850; doi:10.2337/diabetes.43.7.843

  4. Liu, L

    • Isolation of the human LIM/homeodomain gene islet-1 and identification of a simple sequence repeat polymorphism [corrected] Diabetes July 1994 43:935-941; doi:10.2337/diabetes.43.7.935

  5. Lönnroth, P N

    • Effects of hyperglycemia on in vivo adipose tissue metabolism studied with microdialysis in IDDM subjects. Diabetes July 1994 43:866-870; doi:10.2337/diabetes.43.7.866

  6. Lopez, A D

    • Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes July 1994 43:947-953; doi:10.2337/diabetes.43.7.947

M

  1. MacCluer, J W

    • Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes July 1994 43:942-946; doi:10.2337/diabetes.43.7.942

  2. Mazzanti, L

    • Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes July 1994 43:915-919; doi:10.2337/diabetes.43.7.915

  3. McGarry, J D

    • More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling. Diabetes July 1994 43:878-883; doi:10.2337/diabetes.43.7.878

  4. McGill, M

    • Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies. Diabetes July 1994 43:851-856; doi:10.2337/diabetes.43.7.851

  5. McKeon, C

    • Proximal enhancer of the human insulin receptor gene binds the transcription factor Sp1. Diabetes July 1994 43:884-889; doi:10.2337/diabetes.43.7.884

  6. McNally, J M

    • Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies. Diabetes July 1994 43:851-856; doi:10.2337/diabetes.43.7.851

  7. McNeill, J H

    • Bis(maltolato)oxovanadium(IV) attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats. Diabetes July 1994 43:857-861; doi:10.2337/diabetes.43.7.857

  8. Mikines, K J

    • Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes July 1994 43:862-865; doi:10.2337/diabetes.43.7.862

  9. Misericordia, P

    • Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes July 1994 43:920-928; doi:10.2337/diabetes.43.7.920

  10. Morrissey, M

    • The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes July 1994 43:897-902; doi:10.2337/diabetes.43.7.897

N

  1. Nichaman, M Z

    • The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes July 1994 43:897-902; doi:10.2337/diabetes.43.7.897

O

  1. Ogawa, A

    • More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling. Diabetes July 1994 43:878-883; doi:10.2337/diabetes.43.7.878

  2. Ohneda, M

    • More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling. Diabetes July 1994 43:878-883; doi:10.2337/diabetes.43.7.878

  3. Orlander, P R

    • The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes July 1994 43:897-902; doi:10.2337/diabetes.43.7.897

  4. Ostrega, D

    • Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM. Diabetes July 1994 43:871-877; doi:10.2337/diabetes.43.7.871

  5. Otonkoski, T

    • Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes July 1994 43:947-953; doi:10.2337/diabetes.43.7.947

P

  1. Permutt, M A

    • Isolation of the human LIM/homeodomain gene islet-1 and identification of a simple sequence repeat polymorphism [corrected] Diabetes July 1994 43:935-941; doi:10.2337/diabetes.43.7.935

  2. Perriello, G

    • Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes July 1994 43:920-928; doi:10.2337/diabetes.43.7.920

  3. Petersen, L N

    • Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes July 1994 43:862-865; doi:10.2337/diabetes.43.7.862

  4. Ploug, T

    • Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes July 1994 43:862-865; doi:10.2337/diabetes.43.7.862

  5. Polonsky, K S

    • Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM. Diabetes July 1994 43:871-877; doi:10.2337/diabetes.43.7.871

Q

  1. Quon, M J

    • Non-insulin-mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis. Diabetes July 1994 43:890-896; doi:10.2337/diabetes.43.7.890

R

  1. Rabini, R A

    • Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes July 1994 43:915-919; doi:10.2337/diabetes.43.7.915

  2. Rainwater, D L

    • Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes July 1994 43:942-946; doi:10.2337/diabetes.43.7.942

  3. Ramsey, D J

    • The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes July 1994 43:897-902; doi:10.2337/diabetes.43.7.897

  4. Riggs, A C

    • Isolation of the human LIM/homeodomain gene islet-1 and identification of a simple sequence repeat polymorphism [corrected] Diabetes July 1994 43:935-941; doi:10.2337/diabetes.43.7.935

  5. Rubin, J S

    • Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes July 1994 43:947-953; doi:10.2337/diabetes.43.7.947

S

  1. Santeusanio, F

    • Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes July 1994 43:920-928; doi:10.2337/diabetes.43.7.920

  2. Santucci, A

    • Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes July 1994 43:920-928; doi:10.2337/diabetes.43.7.920

  3. Santucci, C

    • Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes July 1994 43:920-928; doi:10.2337/diabetes.43.7.920

  4. Schluter, J

    • Lithium increases susceptibility of muscle glucose transport to stimulation by various agents. Diabetes July 1994 43:903-907; doi:10.2337/diabetes.43.7.903

  5. Shalwitz, R A

    • Time course for effects of hypoglycemia on insulin gene transcription in vivo. Diabetes July 1994 43:929-934; doi:10.2337/diabetes.43.7.929

  6. Solera, M L

    • Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes July 1994 43:915-919; doi:10.2337/diabetes.43.7.915

  7. Stern, M P

    • Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes July 1994 43:942-946; doi:10.2337/diabetes.43.7.942

T

  1. Tabata, I

    • Lithium increases susceptibility of muscle glucose transport to stimulation by various agents. Diabetes July 1994 43:903-907; doi:10.2337/diabetes.43.7.903

  2. Tager, H

    • Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM. Diabetes July 1994 43:871-877; doi:10.2337/diabetes.43.7.871

  3. Tanizawa, Y

    • Isolation of the human LIM/homeodomain gene islet-1 and identification of a simple sequence repeat polymorphism [corrected] Diabetes July 1994 43:935-941; doi:10.2337/diabetes.43.7.935

  4. Taus, M

    • Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes July 1994 43:915-919; doi:10.2337/diabetes.43.7.915

  5. Taylor, S I

    • Proximal enhancer of the human insulin receptor gene binds the transcription factor Sp1. Diabetes July 1994 43:884-889; doi:10.2337/diabetes.43.7.884
    • Non-insulin-mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis. Diabetes July 1994 43:890-896; doi:10.2337/diabetes.43.7.890

U

  1. Unger, R H

    • More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling. Diabetes July 1994 43:878-883; doi:10.2337/diabetes.43.7.878

V

  1. Valdiguie, P

    • Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes July 1994 43:915-919; doi:10.2337/diabetes.43.7.915

  2. VandeBerg, J L

    • Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes July 1994 43:942-946; doi:10.2337/diabetes.43.7.942

  3. van der Merwe, T M

    • Effects of hyperglycemia on in vivo adipose tissue metabolism studied with microdialysis in IDDM subjects. Diabetes July 1994 43:866-870; doi:10.2337/diabetes.43.7.866

  4. Vaxillaire, M

    • Isolation of the human LIM/homeodomain gene islet-1 and identification of a simple sequence repeat polymorphism [corrected] Diabetes July 1994 43:935-941; doi:10.2337/diabetes.43.7.935

  5. Ventura, M M

    • Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes July 1994 43:920-928; doi:10.2337/diabetes.43.7.920

  6. Volpi, E

    • Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes July 1994 43:920-928; doi:10.2337/diabetes.43.7.920

W

  1. Wagner, R

    • Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies. Diabetes July 1994 43:851-856; doi:10.2337/diabetes.43.7.851

  2. Walker, G E

    • Proximal enhancer of the human insulin receptor gene binds the transcription factor Sp1. Diabetes July 1994 43:884-889; doi:10.2337/diabetes.43.7.884

  3. Wear, M L

    • The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes July 1994 43:897-902; doi:10.2337/diabetes.43.7.897

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement